OverviewSuggest Edit

Saniona, a research and development company, engages in the development of drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases and treatment of pain. It has a portfolio of various drug candidates in pre-clinical and clinical stages. The Company's products include Tesofensine, a triple monoamine reuptake inhibitor, which is in Phase III clinical trial to treat obesity; Tesomet, a fix-dose combination of tesofensine and metoprolol that is in Phase II clinical trials for the treatment of metabolic diseases and prader-wills syndromes; NS2359, a triple monoamine reuptake inhibitor that is in Phase II clinical trial for cocaine addiction; and CAD-1883 that is in Phase I clinical trial for ataxia/tremor.

TypePublic
Founded2011
HQBallerup, DK
Websitesaniona.com

Latest Updates

Employees (est.) (Jul 2021)34
Share Price (Nov 2021)KR10.3(+2%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Saniona

Rami Levin

Rami Levin

President and Chief Executive Officer
Jason A. Amello

Jason A. Amello

Chief Financial Officer
Rudolf Baumgartner

Rudolf Baumgartner

Chief Medical Officer and Head of Clinical Development
Trista Morrison

Trista Morrison

Chief Communications Officer
Kyle Haraldsen

Kyle Haraldsen

Chief Technical Operations Officer
Jørgen Drejer

Jørgen Drejer

Founder and Chief Scientific Officer
Show more

Saniona Office Locations

Saniona has offices in Ballerup, Glostrup and Waltham
Ballerup, DK (HQ)
154 Baltorpvej
Glostrup, DK
Smedeland 26B
Waltham, MA, US
10 CityPoint, 500 Totten Pond Rd #620
Show all (3)

Saniona Financials and Metrics

Saniona Revenue

Market capitalization (10-Nov-2021)

640.1m

Closing stock price (10-Nov-2021)

10.3
Saniona's current market capitalization is kr640.1 m.
Show all financial metrics

Saniona Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Saniona Online and Social Media Presence

Embed Graph

Saniona Blogs

Saniona AB’s Nomination Committee for the Annual General Meeting 2022

PRESS RELEASE November 25 , 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the composition of the Nomination Committee for the Annual General Meeting 2022 . Pursuant to the instruction and charter for the Nomination Committee adopted

Saniona publishes its interim report for the third quarter of 2021

Saniona publishes its interim report for the third quarter of 2021 Content Import Thu, 11/18/2021 - 02:00 Saniona publishes its interim report for the third quarter of 2021 November 18, 2021 at 2:00 AM EST This release is a backfill from a News…

Saniona Initiates Phase 2b Clinical Trial of Tesomet for Hypothalamic Obesity

PRESS RELEASE November 1 7 , 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the initiation of a Phase 2b clinical trial of Tesomet in patients with hypothalamic obesity (HO). Tesomet is an investigational fixed-dose combination

Saniona appoints Robert Hoffman to Board of Directors as Chair of the Audit Committee

PRESS RELEASE 1 6 September 202 1 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the appointment of Robert E. Hoffman to its board of directors, as resolved at the extraordinary shareholders’ meeting held on September 16, 2021 .

Bulletin from the Saniona AB extraordinary shareholders’ meeting on September 16, 2021

Bulletin from the Saniona AB extraordinary shareholders’ meeting on September 16, 2021 Content Import Thu, 09/16/2021 - 11:45 Bulletin from the Saniona AB extraordinary shareholders’ meeting on September 16, 2021 September 16, 2021 at 11:45 AM EDT …

Saniona Frequently Asked Questions

  • When was Saniona founded?

    Saniona was founded in 2011.

  • Who are Saniona key executives?

    Saniona's key executives are Rami Levin, Jason A. Amello and Rudolf Baumgartner.

  • How many employees does Saniona have?

    Saniona has 34 employees.

  • Who are Saniona competitors?

    Competitors of Saniona include Zealand Pharma, Acousia Therapeutics and Abliva.

  • Where is Saniona headquarters?

    Saniona headquarters is located at 154 Baltorpvej, Ballerup.

  • Where are Saniona offices?

    Saniona has offices in Ballerup, Glostrup and Waltham.

  • How many offices does Saniona have?

    Saniona has 3 offices.